Anlon Healthcare Ltd vs Dmcc Speciality Chemicals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 29, 2026

Key Highlights

The Latest Trading Price of Anlon Healthcare Ltd is ₹ 116 as of 27 Mar 15:30 . The P/E Ratio of Anlon Healthcare Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of DMCC Speciality Chemicals Ltd changed from 24.4 on March 2021 to 34.8 on March 2025 . This represents a CAGR of 7.36% over 5 years The Market Cap of Anlon Healthcare Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of DMCC Speciality Chemicals Ltd changed from ₹ 793.46 crore on March 2021 to ₹ 748.57 crore on March 2025 . This represents a CAGR of -1.16% over 5 years The revenue of Anlon Healthcare Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of DMCC Speciality Chemicals Ltd for the Dec '25 is ₹ 151.06 crore as compare to the Sep '25 revenue of ₹ 126.34 crore. This represent the growth of 19.57% The ebitda of Anlon Healthcare Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of DMCC Speciality Chemicals Ltd for the Dec '25 is ₹ 14.91 crore as compare to the Sep '25 ebitda of ₹ 14.31 crore. This represent the growth of 4.19% The net profit of Anlon Healthcare Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of DMCC Speciality Chemicals Ltd changed from ₹ 1.37 crore to ₹ 6.17 crore over 7 quarters. This represents a CAGR of 136.30% The Dividend Payout of Anlon Healthcare Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of DMCC Speciality Chemicals Ltd changed from 15.32 % on March 2021 to 28.95 % on March 2025 . This represents a CAGR of 13.57% over 5 years .

About Anlon Healthcare Ltd

Anlon Healthcare Limited was originally incorporated as 'Anlon Ventures Private Limited', dated November 19, 2013 issued by the RoC. The Company changed the name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh Certificate of Incorporation dated May 27, 2015 was issued by the RoC. The status of the Company was subsequently converted to a Public Limited and the name of the Company was changed to 'Anlon Healthcare Limited' dated September 2, 2024 by the RoC. Anlon Healthcare is engaged in manufacturing of Pharma Intermediates and APIs.
They are one of the few manufacturers of loxoprofen sodium dihydrate in India, a notable API , widely used in treatment of pain/inflammation association with conditions including rheumatoid arthritis, osteoarthritis, lower back pain, frozen shoulder, neck-shoulder-arm syndrome, tooth pain or after surgery, injury or tooth extraction.

About DMCC Speciality Chemicals Ltd

DMCC Speciality Chemicals Limited was erstwhile incorporated as 'Dharamsi Morarji Chemicals Company Limited' on September 25, 1919.
The Company's changed the name from 'Dharamsi Morarji Chemicals Company Limited' to 'DMCC Speciality Chemicals Limited' on August 12, 2022.
Promoted by the Late Ratansi D Morarji to manufacture chemicals at Ambernath, Company is a pioneer in the Indian chemical industry.
With a rich legacy spanning over a century, DMCC has evolved from being India's first producer of sulphuric acid and phosphate fertilisers to a fully integrated speciality chemicals player. The Company's diverse product portfolio includes bulk chemicals such as sulphuric acid, oleum, and chloro sulphonic acid, as well as a range of speciality chemicals catering to industries like textiles, pharmaceuticals, agrochemicals, and water treatment.

FAQs for the comparison of Anlon Healthcare Ltd and DMCC Speciality Chemicals Ltd

Which company has a larger market capitalization, Anlon Healthcare Ltd or DMCC Speciality Chemicals Ltd?

Market cap of Anlon Healthcare Ltd is 616 Cr while Market cap of DMCC Speciality Chemicals Ltd is 515 Cr

What are the key factors driving the stock performance of Anlon Healthcare Ltd and DMCC Speciality Chemicals Ltd?

The stock performance of Anlon Healthcare Ltd and DMCC Speciality Chemicals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anlon Healthcare Ltd and DMCC Speciality Chemicals Ltd?

As of March 29, 2026, the Anlon Healthcare Ltd stock price is INR ₹116.0. On the other hand, DMCC Speciality Chemicals Ltd stock price is INR ₹206.6.

How do dividend payouts of Anlon Healthcare Ltd and DMCC Speciality Chemicals Ltd compare?

To compare the dividend payouts of Anlon Healthcare Ltd and DMCC Speciality Chemicals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.